Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF

Citation
A. Strandell et al., Hydrosalpinx and IVF outcome: a prospective, randomized multicentre trial in Scandinavia on salpingectomy prior to IVF, HUM REPR, 14(11), 1999, pp. 2762-2769
Citations number
40
Categorie Soggetti
Reproductive Medicine","da verificare
Journal title
HUMAN REPRODUCTION
ISSN journal
02681161 → ACNP
Volume
14
Issue
11
Year of publication
1999
Pages
2762 - 2769
Database
ISI
SICI code
0268-1161(199911)14:11<2762:HAIOAP>2.0.ZU;2-3
Abstract
Many retrospective studies have shown that hydrosalpinx is associated with poor in-vitro fertilization (IVF) outcome. The mechanism of the actual caus e is not yet fully understood. A clinical practice of performing salpingect omy before NF has developed, without any evidence from prospective trials. The aim of the present prospective randomized trial was to test if a salpin gectomy prior to IVF was effective in terms of increased pregnancy rates. P atients with hydrosalpinx were randomized to either a laparoscopic salpinge ctomy or no intervention before IVF. A total of 204 patients was available for an intention-to-treat analysis and 192 actually started IVF, Clinical p regnancy rates per included patient were 36.6% in the salpingectomy group a nd 23.9% in the non-intervention group (not significant, P = 0.067) and the ensuing delivery rates were 28.6% and 16.3% (P = 0.045), The corresponding delivery rates per transfer cycle were 29.5% versus 17.5% (not significant , P = 0.083), A subgroup analysis revealed significant differences in favou r of salpingectomy, in implantation rates in patients with bilateral hydros alpinges (25.6% versus 12.3%, P = 0.038) and in clinical pregnancy rates (4 5.7% versus 22.5%, P = 0.029) and delivery rates (40.0% versus 17.5%, P = 0 .038) in patients with ultrasound visible hydrosalpinges. The delivery rate was increased 3.5-fold in patients with bilateral hydrosalpinges visible o n ultrasound (P = 0.019).